文献速递乳房整形与再造显微修复重建

术前化疗与DIEP皮瓣乳房重建显微血管并发症的回顾性研究

Chemotherapy and microsurgical-related vascular complications in DIEP flap breast reconstruction: A retrospective study.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2026-10-09

丹麦奥胡斯大学医院回顾2020年1月至2024年10月共278例DIEP皮瓣乳房重建,其中160例(57.6%)术前接受过化疗,化疗至手术中位间隔641天。单因素与多因素分析均未发现术前化疗或化疗时机与显微血管并发症相关,支持在该背景下行重建的安全性。

要点

  • 术前化疗组与未化疗组的血管并发症风险无差异
  • 化疗至手术间隔与血管并发症无关联
  • 多数重建在化疗后较长时间进行,支持安全性

核心结论

  • 在本队列中,术前化疗及化疗至DIEP皮瓣重建的时间间隔与显微手术相关血管并发症无关联,支持该背景下重建的安全性。

研究设计与样本

  • 单中心回顾性队列研究,纳入2020年1月至2024年10月奥胡斯大学医院整形与乳腺外科所有DIEP皮瓣乳房重建,共278例。

主要发现

  • 160例(57.6%)术前接受化疗,化疗至手术中位间隔641天(IQR 410-924天),118例(42.4%)未术前化疗。
  • 单因素和多因素分析均未观察到再吻合、血肿、皮瓣丢失、复合血管结局、感染或轻微并发症的比值差异。
  • 化疗与手术的间隔时间与血管并发症无关联。

临床怎么用

  • 对需术前化疗的DIEP皮瓣乳房重建患者,可结合本队列结果评估显微血管并发症风险,不必因化疗间隔较长而延迟重建。

局限性

  • 为单中心回顾性研究,作者指出需更大规模多中心研究验证化疗时机与具体方案的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the association between preoperative chemotherapy and microsurgical vascular complications in patients undergoing deep inferior epigastric perforator (DIEP) flap breast reconstruction and whether chemotherapy timing affects risk. METHODS: A retrospective cohort study was conducted at the Department of Plastic and Breast Surgery, Aarhus University Hospital, by including all patients who underwent DIEP flap breast reconstructions from January 2020 to October 2024. Reconstructions were grouped as exposed to preoperative chemotherapy (any chemotherapy before reconstruction) and compared to no preoperative chemotherapy (none or >90 days postoperatively). Data on predefined patient and tumor characteristics, intervention details, chemotherapy exposure, and microsurgical vascular complications were extracted from medical records and analyzed using univariate and multivariate logistic regression. RESULTS: In total, 278 DIEP flap breast reconstructions were included. Preoperative chemotherapy was administered in 160 (57.6%) reconstructions, with a median interval of 641 days before reconstruction (IQR 410-924 days), whereas 118 (42.4%) reconstructions were performed without preoperative chemotherapy. No differences in the odds of vascular complications, including reanastomosis, hematoma, flap loss, composite vascular outcome, infection, or minor complications were observed between the groups, in either univariate or multivariate analyzes. The interval between chemotherapy and surgery was not associated with vascular complications. CONCLUSION: In this cohort, most reconstructions were performed long after chemotherapy exposure, and preoperative chemotherapy and time from chemotherapy to DIEP flap breast reconstruction were not associated with microsurgery-related vascular complications. These findings support the safety of reconstruction in this setting. Larger multicenter studies are warranted to validate the role of chemotherapy timing and specific regimens.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Søndberg VKS, Lautrup MD, Saritas S, et al. Chemotherapy and microsurgical-related vascular complications in DIEP flap breast reconstruction: A retrospective study. J Plast Reconstr Aesthet Surg. 2026. PMID: 42913249. doi:10.1016/j.bjps.2026.10.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。